Masashi Sawa

2.1k total citations
94 papers, 646 citations indexed

About

Masashi Sawa is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Masashi Sawa has authored 94 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Hematology, 30 papers in Public Health, Environmental and Occupational Health and 21 papers in Oncology. Recurrent topics in Masashi Sawa's work include Hematopoietic Stem Cell Transplantation (61 papers), Acute Myeloid Leukemia Research (35 papers) and Acute Lymphoblastic Leukemia research (30 papers). Masashi Sawa is often cited by papers focused on Hematopoietic Stem Cell Transplantation (61 papers), Acute Myeloid Leukemia Research (35 papers) and Acute Lymphoblastic Leukemia research (30 papers). Masashi Sawa collaborates with scholars based in Japan, United States and Norway. Masashi Sawa's co-authors include Yoshiko Atsuta, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Tatsuo Ichinohe, Yoshinobu Kanda, Makoto Onizuka, Akio Kohno, Masamitsu Yanada and Masatsugu Tanaka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Masashi Sawa

85 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masashi Sawa Japan	14	456	158	157	149	109	94	646
Ivan Pašić Canada	12	238 0.5×	164 1.0×	85 0.5×	121 0.8×	56 0.5×	80	514
Nan Young Lee South Korea	14	306 0.7×	120 0.8×	64 0.4×	174 1.2×	176 1.6×	41	545
Rayaz Ahmed India	12	286 0.6×	122 0.8×	110 0.7×	104 0.7×	56 0.5×	55	459
Giuseppe Console Italy	15	475 1.0×	130 0.8×	60 0.4×	302 2.0×	90 0.8×	51	633
Minako Iida Japan	7	290 0.6×	80 0.5×	82 0.5×	102 0.7×	105 1.0×	13	436
Keiren Kirkland United Kingdom	11	297 0.7×	84 0.5×	61 0.4×	162 1.1×	86 0.8×	24	458
Woo‐Sung Min South Korea	14	323 0.7×	87 0.6×	136 0.9×	104 0.7×	61 0.6×	34	451
Olga Militano United States	12	247 0.5×	55 0.3×	134 0.9×	176 1.2×	54 0.5×	42	446
Meiqing Wu China	10	256 0.6×	54 0.3×	85 0.5×	134 0.9×	86 0.8×	40	442
SJ Forman United States	8	413 0.9×	57 0.4×	121 0.8×	116 0.8×	100 0.9×	8	517

Countries citing papers authored by Masashi Sawa

Since Specialization

Citations

This map shows the geographic impact of Masashi Sawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Sawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Sawa more than expected).

Fields of papers citing papers by Masashi Sawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Sawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Sawa. The network helps show where Masashi Sawa may publish in the future.

Co-authorship network of co-authors of Masashi Sawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Sawa. A scholar is included among the top collaborators of Masashi Sawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Sawa. Masashi Sawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Terakura, Seitaro, Yuki Takeuchi, Takahiko Sato, et al.. (2025). Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study. Cytotherapy. 27(8). 962–972.

Asano, Takashi, et al.. (2024). Relationship between Early-onset Adverse Events and Drug Plasma Concentrations in Patients Receiving Oral Voriconazole. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 50(9). 494–503.

Tamaki, Masaharu, Yu Akahoshi, Yoshihiro Inamoto, et al.. (2024). Associations between acute and chronic graft-versus-host disease. Blood Advances. 8(16). 4250–4261.

Jo, Tomoyasu, Yu Akahoshi, Tadakazu Kondo, et al.. (2024). First complete remission favours haploidentical haematopoietic stem cell transplantation with post‐transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 204(5). 1913–1919. 2 indexed citations

Konuma, Takaaki, Kotaro Miyao, Hideki Nakasone, et al.. (2024). Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period. Cytotherapy. 26(8). 910–920. 2 indexed citations

Itonaga, Hidehiro, Yasushi Miyazaki, Kazunari Aoki, et al.. (2023). Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database. Annals of Hematology. 102(5). 1215–1227. 1 indexed citations

Tamaki, Masaharu, Yu Akahoshi, Yosuke Okada, et al.. (2023). Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients. Cytotherapy. 25(11). 1220–1228. 1 indexed citations

Konuma, Takaaki, Hidehiro Itonaga, Ken Ishiyama, et al.. (2023). Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?. Bone Marrow Transplantation. 58(8). 893–906. 2 indexed citations

Imahashi, Nobuhiko, Naoki Kurita, Takaaki Konuma, et al.. (2023). Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens. Transplantation and Cellular Therapy. 30(3). 318.e1–318.e11.

10.

Suzuki, Kazuhito, Yutaka Shimazu, Takashi Ikeda, et al.. (2023). Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis. Transplantation and Cellular Therapy. 29(11). 688.e1–688.e13. 3 indexed citations

11.

Konuma, Takaaki, Junya Kanda, Yachiyo Kuwatsuka, et al.. (2021). Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type. Clinical Cancer Research. 27(17). 4825–4835. 15 indexed citations

12.

Fujimoto, Ayumi, Tatsuhiko Anzai, Takahiro Fukuda, et al.. (2021). Impact of Event-Free Survival Status after Stem Cell Transplantation on Subsequent Survival in Lymphoma Patients. Transplantation and Cellular Therapy. 27(3). S62–S65.

13.

Arai, Yasuyuki, Shigeki Hirabayashi, Tadakazu Kondo, et al.. (2021). Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy‐refractory or relapsed disease prior to allogeneic stem cell transplantation. British Journal of Haematology. 194(2). 403–413. 2 indexed citations

14.

Yanada, Masamitsu, Shuichi Ota, Miho Nara, et al.. (2021). Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis. Bone Marrow Transplantation. 57(1). 78–82. 5 indexed citations

15.

Nishiwaki, Satoshi, Yu Akahoshi, Shuichi Mizuta, et al.. (2021). Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2. Blood Advances. 5(2). 584–592. 6 indexed citations

16.

Kaito, Satoshi, Yuho Najima, Kaito Harada, et al.. (2020). Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. Bone Marrow Transplantation. 55(7). 1337–1346. 5 indexed citations

17.

Yanada, Masamitsu, Takaaki Konuma, Satoshi Yamasaki, et al.. (2020). Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes. Bone Marrow Transplantation. 56(5). 1126–1133. 26 indexed citations

18.

Yanada, Masamitsu, Takaaki Konuma, Shohei Mizuno, et al.. (2020). Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia. Bone Marrow Transplantation. 56(2). 387–394. 13 indexed citations

19.

Terakura, Seitaro, Kazuteru Ohashi, Takahiro Fukuda, et al.. (2019). Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. Blood Advances. 3(2). 105–115. 16 indexed citations

20.

Yanada, Masamitsu, Takaaki Konuma, Yachiyo Kuwatsuka, et al.. (2019). Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience. Bone Marrow Transplantation. 54(11). 1789–1798. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact